Robert A. Bradway has been appointed president and chief operating officer of Amgen, effective May 11. Mr. Bradway will be responsible for the company’s Global Commercial Operations, Manufacturing Operations, Strategy and Corporate Development, Information Technology, Global Government Affairs and Compliance. He will report to Kevin Sharer, Amgen’s chairman and chief executive officer. Mr. Bradway has served as the company’s executive vice president and chief financial offic...